Drug profile · INN
tetrahydrozoline hydrochloride
TYZINE
tetrahydrozoline hydrochloride (TYZINE) is a adrenergic receptor alpha agonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — tetrahydrozoline hydrochloride
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tetrahydrozoline hydrochloride (TYZINE) is a adrenergic receptor alpha agonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha agonist
Primary target: Adrenergic receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tetrahydrozoline hydrochloride?
tetrahydrozoline hydrochloride (TYZINE) is a adrenergic receptor alpha agonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for tetrahydrozoline hydrochloride?
TYZINE is a marketed brand name for tetrahydrozoline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tetrahydrozoline hydrochloride?
tetrahydrozoline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.